NA Electronic Clinical Outcome Assessment (eCOA) Market - Industry Trends and Forecast to 2035

TABLE OF CONTENTS

1 INTRODUCTION 16

• 1.1 OBJECTIVES OF THE STUDY 16
• 1.2 MARKET DEFINITION 16
• 1.3 OVERVIEW OF THE NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET 16
• 1.4 LIMITATIONS 17
• 1.5 MARKETS COVERED 18

2 MARKET SEGMENTATION 20

• 2.1 MARKETS COVERED 20
• 2.2 GEOGRAPHICAL SCOPE 21
• 2.3 YEARS CONSIDERED FOR THE STUDY 22
• 2.4 CURRENCY AND PRICING 22
• 2.5 DBMR TRIPOD DATA VALIDATION MODEL 23
• 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 26
• 2.7 DBMR MARKET POSITION GRID 27
• 2.8 VENDOR SHARE ANALYSIS 29
• 2.9 MULTIVARIATE MODELLING 30
• 2.10 TYPE TIMELINE CURVE 31
• 2.11 MARKET APPLICATION COVERAGE GRID 32
• 2.12 SECONDARY SOURCES 33
• 2.13 ASSUMPTIONS 33

3 EXECUTIVE SUMMARY 34

4 PREMIUM INSIGHTS 36

• 4.1 PESTEL ANALYSIS 37
• 4.2 PORTER'S FIVE FORCES ANALYSIS 38

5 REGULATORY FRAMEWORK 39

6 MARKET OVERVIEW 41

• 6.1 DRIVERS 43
  • 6.1.1 GROWING ACCEPTANCE OF ECOA AMONG CLINICAL RESEARCH PROFESSIONALS 43
  • 6.1.2 PARADIGM SHIFT TOWARDS ELECTRONIC DATA CAPTURING FROM PAPER-BASED PROCEDURES 44
  • 6.1.3 GOVERNMENT INITIATIVES ABOUT THE ADOPTION OF ECLINICAL PLATFORMS 45
• 6.2 RESTRAINTS 46
  • 6.2.1 IMPLEMENTATION OF 'BRING YOUR OWN DEVICE' (BYOD) TECHNOLOGY IN CLINICAL TRIALS 46
  • 6.2.2 LACK OF PROPER HEALTHCARE IT INFRASTRUCTURE IN DEVELOPING COUNTRIES 47
• 6.3 OPPORTUNITIES 47
  • 6.3.1 GROWING ADOPTION OF CLOUD-BASED SERVICES 47
  • 6.3.2 RISING NUMBER OF RESEARCH STUDIES FOCUSING ON CLINICAL OUTCOME ASSESSMENTS 48
• 6.4 CHALLENGES 49
  • 6.4.1 DIFFICULTIES ASSOCIATED WITH TRAINING OF RESPONDENTS TO FILL ELECTRONIC QUESTIONNAIRES 49
  • 6.4.2 STREAMLINING OF ECOA SERVICES 49

7 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE 51

• 7.1 OVERVIEW 52
• 7.2 CLINICIAN REPORTED OUTCOME ASSESSMENT (CLINRO) 53
• 7.3 PATIENT REPORTED OUTCOME ASSESSMENT (PRO) 54
• 7.4 OBSERVER REPORTED OUTCOME ASSESSMENT (OBSRO) 54
• 7.5 PERFORMANCE OUTCOME ASSESSMENT (PERFO) 55

8 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY 56

• 8.1 OVERVIEW 57
• 8.2 SITE-BASED SOLUTIONS 58
• 8.3 WEB SOLUTIONS 59
• 8.4 HANDHELD 59
  • 8.4.1 BRING-YOUR-OWN-DEVICE (BYOD) 60
  • 8.4.2 PROVISIONED DEVICES 60

9 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER 61

• 9.1 OVERVIEW 62
• 9.2 CONTRACT RESEARCH ORGANIZATIONS (CROS) 63
  • 9.2.1 SITE-BASED SOLUTIONS 64
  • 9.2.2 WEB SOLUTIONS 64
  • 9.2.3 HANDHELD 64
• 9.3 PHARMACEUTICAL AND BIOTECHNOLOGY FIRMS 64
  • 9.3.1 SITE-BASED SOLUTIONS 65
  • 9.3.2 WEB SOLUTIONS 65
  • 9.3.3 HANDHELD 65
• 9.4 MEDICAL DEVICE COMPANIES 65
  • 9.4.1 SITE-BASED SOLUTIONS 66
  • 9.4.2 WEB SOLUTIONS 66
  • 9.4.3 HANDHELD 66
• 9.5 HOSPITALS/HEALTHCARE PROVIDERS 66
  • 9.5.1 SITE-BASED SOLUTIONS 67
  • 9.5.2 WEB SOLUTIONS 67
  • 9.5.3 HANDHELD 67
• 9.6 CONSULTING SERVICE COMPANIES 67
  • 9.6.1 SITE-BASED SOLUTIONS 68
  • 9.6.2 WEB SOLUTIONS 68
  • 9.6.3 HANDHELD 68
• 9.7 ACADEMIC & RESEARCH INSTITUTES 68
  • 9.7.1 SITE-BASED SOLUTIONS 69
  • 9.7.2 WEB SOLUTIONS 69
  • 9.7.3 HANDHELD 69
• 9.8 OTHERS 69
  • 9.8.1 SITE-BASED SOLUTIONS 70
  • 9.8.2 WEB SOLUTIONS 70
  • 9.8.3 HANDHELD 70

10 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY DELIVERY MODE 71

• 10.1 OVERVIEW 72
• 10.2 CLOUD-BASED 73
• 10.3 WEB-HOSTED 73

11 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION 74

• 11.1 NORTH AMERICA 76
  • 11.1.1 U.S. 81
  • 11.1.2 CANADA 86
  • 11.1.3 MEXICO 90

12 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: COMPANY LANDSCAPE 95

• 12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 95

13 SWOT ANALYSIS 96

14 COMPANY PROFILE 97

• 14.1 MEDIDATA 97
  • 14.1.1 COMPANY SNAPSHOT 97
  • 14.1.2 REVENUE ANALYSIS 97
  • 14.1.3 COMPANY SHARE ANALYSIS 98
  • 14.1.4 SOLUTION PORTFOLIO 98
  • 14.1.5 RECENT DEVELOPMENTS 98
• 14.2 IQVIA INC 101
  • 14.2.1 COMPANY SNAPSHOT 101
  • 14.2.2 REVENUE ANALYSIS 101
  • 14.2.3 COMPANY SHARE ANALYSIS 102
  • 14.2.4 PRODUCT PORTFOLIO 102
  • 14.2.5 RECENT DEVELOPMENTS 102
• 14.3 CLARIO 104
  • 14.3.1 COMPANY SNAPSHOT 104
  • 14.3.2 COMPANY SHARE ANALYSIS 104
  • 14.3.3 SOLUTION PORTFOLIO 105
  • 14.3.4 RECENT DEVELOPMENTS 105
• 14.4 SIGNANT HEALTH 107
  • 14.4.1 COMPANY SNAPSHOT 107
  • 14.4.2 SOLUTION PORTFOLIO 107
  • 14.4.3 RECENT DEVELOPMENTS 108
• 14.5 ARIS NORTH AMERICA 109
  • 14.5.1 COMPANY SNAPSHOT 109
  • 14.5.2 SOLUTION PORTFOLIO 109
  • 14.5.3 RECENT DEVELOPMENTS 111
• 14.6 ASSISTEK 113
  • 14.6.1 COMPANY SNAPSHOT 113
  • 14.6.2 SERVICE PORTFOLIO 113
  • 14.6.3 RECENT DEVELOPMENT 114
• 14.7 CASTOR 115
  • 14.7.1 COMPANY SNAPSHOT 115
  • 14.7.2 PRODUCT PORTFOLIO 115
  • 14.7.3 RECENT DEVELOPMENTS 116
• 14.8 CLIMEDO HEALTH GMBH 117
  • 14.8.1 COMPANY SNAPSHOT 117
  • 14.8.2 PRODUCT PORTFOLIO 117
  • 14.8.3 RECENT DEVELOPMENT 117

• 14.9 CLINCAPTURE 118
  • 14.9.1 COMPANY SNAPSHOT 118
  • 14.9.2 PRODUCT PORTFOLIO 118
  • 14.9.3 RECENT DEVELOPMENT 118
• 14.10 CLINICAL INK 119
  • 14.10.1 COMPANY SNAPSHOT 119
  • 14.10.2 SOLUTION PORTFOLIO 119
  • 14.10.3 RECENT DEVELOPMENTS 120
• 14.11 CLOUDBYZ 121
  • 14.11.1 COMPANY SNAPSHOT 121
  • 14.11.2 SOLUTION PORTFOLIO 121
  • 14.11.3 RECENT DEVELOPMENTS 121
• 14.12 CRUCIAL DATA SOLUTIONS 123
  • 14.12.1 COMPANY SNAPSHOT 123
  • 14.12.2 SOLUTION PORTFOLIO 123
  • 14.12.3 RECENT DEVELOPMENTS 123
• 14.13 EVIDENTIQ 125
  • 14.13.1 COMPANY SNAPSHOT 125
  • 14.13.2 PRODUCT PORTFOLIO 125
  • 14.13.3 RECENT DEVELOPMENTS 126
• 14.14 KAYENTIS 127
  • 14.14.1 COMPANY SNAPSHOT 127
  • 14.14.2 SOLUTION PORTFOLIO 127
  • 14.14.3 RECENT DEVELOPMENTS 127
• 14.15 MEDABLE INC. 129
  • 14.15.1 COMPANY SNAPSHOT 129
  • 14.15.2 PRODUCT PORTFOLIO 129
  • 14.15.3 RECENT DEVELOPMENTS 130
• 14.16 MERATIVE 131
  • 14.16.1 COMPANY SNAPSHOT 131
  • 14.16.2 SOLUTION PORTFOLIO 131
  • 14.16.3 RECENT DEVELOPMENTS 131
• 14.17 PATTERN HEALTH TECHNOLOGIES, INC. 133
  • 14.17.1 COMPANY SNAPSHOT 133
  • 14.17.2 SERVICE PORTFOLIO 133
  • 14.17.3 RECENT DEVELOPMENTS 133
• 14.18 RAYLYTIC GMBH 135
  • 14.18.1 COMPANY SNAPSHOT 135
  • 14.18.2 SOLUTION PORTFOLIO 135
  • 14.18.3 RECENT DEVELOPMENT 136
• 14.19 SUVODA LLC 137
  • 14.19.1 COMPANY SNAPSHOT 137
  • 14.19.2 PRODUCT PORTFOLIO 137
  • 14.19.3 RECENT DEVELOPMENT 138
• 14.20 TRANSPERFECT LIFE SCIENCES 139
  • 14.20.1 COMPANY SNAPSHOT 139
  • 14.20.2 SOLUTION PORTFOLIO 139
  • 14.20.3 RECENT DEVELOPMENT 140
• 14.21 VITALOGRAPH 141
  • 14.21.1 COMPANY SNAPSHOT 141
  • 14.21.2 SERVICES PORTFOLIO 141
  • 14.21.3 RECENT DEVELOPMENTS 142
• 14.22 WCG CLINICAL 143
  • 14.22.1 COMPANY SNAPSHOT 143
  • 14.22.2 PRODUCT PORTFOLIO 143
  • 14.22.3 RECENT DEVELOPMENT 143
• 14.23 YPRIME LLC. 145
  • 14.23.1 COMPANY SNAPSHOT 145
  • 14.23.2 SOLUTION PORTFOLIO 145
  • 14.23.3 RECENT DEVELOPMENTS 146

15 QUESTIONNAIRE 148

16 RELATED REPORTS 151

LIST OF TABLES

• TABLE 1 COST COMPARISON - PAPER COA TO ECOA 45
• TABLE 2 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 53
• TABLE 3 NORTH AMERICA CLINICIAN REPORTED OUTCOME ASSESSMENT (CLINRO) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 53
• TABLE 4 NORTH AMERICA PATIENT REPORTED OUTCOME ASSESSMENT (PRO) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 54
• TABLE 5 NORTH AMERICA OBSERVER REPORTED OUTCOME ASSESSMENT (OBSRO) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 54
• TABLE 6 NORTH AMERICA PERFORMANCE OUTCOME ASSESSMENT (PERFO) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 55
• TABLE 7 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 58
• TABLE 8 NORTH AMERICA SITE-BASED SOLUTIONS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 58
• TABLE 9 NORTH AMERICA WEB SOLUTIONS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 59
• TABLE 10 NORTH AMERICA HANDHELD IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 59
• TABLE 11 NORTH AMERICA HANDHELD IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 60
• TABLE 12 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER, 2022-2031 (USD THOUSAND) 63
• TABLE 13 NORTH AMERICA CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 63
• TABLE 14 NORTH AMERICA CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 64
• TABLE 15 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGY FIRMS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 64
• TABLE 16 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGY FIRMS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 65
• TABLE 17 NORTH AMERICA MEDICAL DEVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 65
• TABLE 18 NORTH AMERICA MEDICAL DEVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 66
• TABLE 19 NORTH AMERICA HOSPITALS/HEALTHCARE PROVIDERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 66
• TABLE 20 NORTH AMERICA HOSPITALS/HEALTHCARE PROVIDERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 67
• TABLE 21 NORTH AMERICA CONSULTING SERVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 67
• TABLE 22 NORTH AMERICA CONSULTING SERVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 68
• TABLE 23 NORTH AMERICA ACADEMIC & RESEARCH INSTITUTES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 68
• TABLE 24 NORTH AMERICA ACADEMIC & RESEARCH INSTITUTES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 69
• TABLE 25 NORTH AMERICA OTHERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 69
• TABLE 26 NORTH AMERICA OTHERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 70
• TABLE 27 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY DELIVERY MODE, 2022-2031 (USD THOUSAND) 73
• TABLE 28 NORTH AMERICA CLOUD-BASED IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 73
• TABLE 29 NORTH AMERICA WEB-HOSTED IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 73
• TABLE 30 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND) 76
• TABLE 31 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 76
• TABLE 32 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 77
• TABLE 33 NORTH AMERICA HANDHELD IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 77
• TABLE 34 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER, 2022-2031 (USD THOUSAND) 77
• TABLE 35 NORTH AMERICA CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 78
• TABLE 36 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGY FIRMS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 78
• TABLE 37 NORTH AMERICA MEDICAL DEVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 78
• TABLE 38 NORTH AMERICA HOSPITALS/HEALTHCARE PROVIDERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 79
• TABLE 39 NORTH AMERICA CONSULTING SERVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 79
• TABLE 40 NORTH AMERICA ACADEMIC & RESEARCH INSTITUTES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 79
• TABLE 41 NORTH AMERICA OTHERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 80
• TABLE 42 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY DELIVERY MODE 2022-2031 (USD THOUSAND) 80
• TABLE 43 U.S. ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 81
• TABLE 44 U.S. ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 81
• TABLE 45 U.S. HANDHELD IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 81
• TABLE 46 U.S. ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER, 2022-2031 (USD THOUSAND) 82
• TABLE 47 U.S. CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 82
• TABLE 48 U.S. PHARMACEUTICAL AND BIOTECHNOLOGY FIRMS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 83
• TABLE 49 U.S. MEDICAL DEVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 83
• TABLE 50 U.S. HOSPITALS/HEALTHCARE PROVIDERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 83
• TABLE 51 U.S. CONSULTING SERVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 84
• TABLE 52 U.S. ACADEMIC & RESEARCH INSTITUTES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 84
• TABLE 53 U.S. OTHERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 84
• TABLE 54 U.S. ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY DELIVERY MODE 2022-2031 (USD THOUSAND) 85
• TABLE 55 CANADA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 86
• TABLE 56 CANADA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 86
• TABLE 57 CANADA HANDHELD IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 86
• TABLE 58 CANADA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER, 2022-2031 (USD THOUSAND) 87
• TABLE 59 CANADA CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 87
• TABLE 60 CANADA PHARMACEUTICAL AND BIOTECHNOLOGY FIRMS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 87
• TABLE 61 CANADA MEDICAL DEVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 88
• TABLE 62 CANADA HOSPITALS/HEALTHCARE PROVIDERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 88
• TABLE 63 CANADA CONSULTING SERVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 88
• TABLE 64 CANADA ACADEMIC & RESEARCH INSTITUTES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 89
• TABLE 65 CANADA OTHERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 89
• TABLE 66 CANADA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY DELIVERY MODE 2022-2031 (USD THOUSAND) 89
• TABLE 67 MEXICO ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 90
• TABLE 68 MEXICO ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 90
• TABLE 69 MEXICO HANDHELD IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 90
• TABLE 70 MEXICO ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER, 2022-2031 (USD THOUSAND) 91
• TABLE 71 MEXICO CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 91
• TABLE 72 MEXICO PHARMACEUTICAL AND BIOTECHNOLOGY FIRMS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 92
• TABLE 73 MEXICO MEDICAL DEVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 92
• TABLE 74 MEXICO HOSPITALS/HEALTHCARE PROVIDERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 92
• TABLE 75 MEXICO CONSULTING SERVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 93
• TABLE 76 MEXICO ACADEMIC & RESEARCH INSTITUTES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 93
• TABLE 77 MEXICO OTHERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 93
• TABLE 78 MEXICO ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY DELIVERY MODE 2022-2031 (USD THOUSAND) 94

LIST OF FIGURES

• FIGURE 1 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: SEGMENTATION 20
• FIGURE 2 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: DATA TRIANGULATION 23
• FIGURE 3 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: DROC ANALYSIS 24
• FIGURE 4 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS 25
• FIGURE 5 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: COMPANY RESEARCH ANALYSIS 25
• FIGURE 6 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: INTERVIEW DEMOGRAPHICS 26
• FIGURE 7 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: DBMR MARKET POSITION GRID 27
• FIGURE 8 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: VENDOR SHARE ANALYSIS 29
• FIGURE 9 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: MULTIVARIATE MODELLING 30
• FIGURE 10 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: TYPE TIMELINE CURVE 31
• FIGURE 11 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: MARKET APPLICATION COVERAGE GRID 32
• FIGURE 12 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: SEGMENTATION 35
• FIGURE 13 GROWING ACCEPTANCE OF ECOA AMONG CLINICAL RESEARCH PROFESSIONALS IS DRIVING THE GROWTH OF THE NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET IN THE FORECAST PERIOD OF 2024 TO 2031 36
• FIGURE 14 THE CLINICIAN REPORTED OUTCOME ASSESSMENT (CLINRO) SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET IN 2024 AND 2031 36
• FIGURE 15 PESTEL ANALYSIS: NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET 37
• FIGURE 16 PORTER'S FIVE FORCES ANALYSIS: NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET 38
• FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET 42
• FIGURE 18 ADOPTION OF APPLICATIONS TO MANAGE CLINICAL STUDIES 44
• FIGURE 19 CLOUD SHIFT PROPORTION, BY CATEGORY 48
• FIGURE 20 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: BY TYPE, 2023 52
• FIGURE 21 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: BY MODALITY, 2023 57
• FIGURE 22 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: BY END USER, 2023 62
• FIGURE 23 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: BY DELIVERY MODE, 2023 72
• FIGURE 24 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: SNAPSHOT (2023) 75
• FIGURE 25 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: COMPANY SHARE 2023 (%) 95